The share price of Vir Biotechnology, Inc. (VIR) now
What analysts predict: $29.75
52-week High/Low: $31.55 / $7.72
50/200 Day Moving Average:
$8.89 / $18.28
This figure corresponds to the Average Price over the previous 50/200 days.
For Vir Biotechnology stocks, the 50-day moving average is the support level today.
For Vir Biotechnology stocks, the 200-day moving average is the resistance level today.
Are you interested in Vir Biotechnology, Inc. stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the Vir Biotechnology
stock price in 2023, 2024, 2025, 2026, 2027.
How much will one Vir Biotechnology share be worth in
2023 - 2027?
When should I take profit in Vir Biotechnology stock?
When should I record a loss on Vir Biotechnology stock?
What are analysts' forecasts for Vir Biotechnology stock?
What is the future of Vir Biotechnology stock?
We forecast Vir Biotechnology stock performance using neural networks based on historical data on Vir Biotechnology stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Vir Biotechnology stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2023, 2024, 2025, 2026 and 2027)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Vir Biotechnology shares. This happens once a day.
Historical and forecast chart of Vir Biotechnology stock
The chart below shows the historical price of Vir Biotechnology stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Vir Biotechnology stock price can be found in the table below.
Long-term forecasts by years.
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products for the treatment and prevention of serious infectious diseases. He is developing VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; and VIR-2020 for the prevention of tuberculosis.
Trending Themes in the Healthcare Sector
Vir Biotechnology daily forecast for a month
Date
Target
Pes.
Opt.
Vol., %
Dec 05
10.17
10.01
10.40
3.86
Dec 06
10.36
10.06
10.54
4.79
Dec 07
9.99
9.64
10.23
6.11
Dec 08
9.73
9.52
10.12
6.23
Dec 09
9.54
9.18
9.90
7.90
Dec 10
9.58
9.47
9.87
4.30
Dec 11
9.42
9.16
9.71
5.91
Dec 12
9.24
8.87
9.51
7.24
Dec 13
9.36
9.21
9.68
5.08
Dec 14
9.20
8.87
9.32
4.97
Dec 15
9.13
8.90
9.34
4.97
Dec 16
8.99
8.83
9.19
4.07
Dec 17
8.89
8.54
9.01
5.52
Dec 18
9.10
8.92
9.31
4.33
Dec 19
9.16
8.83
9.31
5.34
Dec 20
9.29
9.18
9.43
2.73
Dec 21
9.35
8.98
9.67
7.76
Dec 22
9.78
9.57
10.13
5.93
Dec 23
9.78
9.52
10.05
5.49
Dec 24
10.00
9.63
10.22
6.18
Dec 25
9.78
9.42
10.04
6.65
Dec 26
9.58
9.37
9.82
4.81
Dec 27
9.52
9.14
9.86
7.86
Dec 28
9.33
9.15
9.57
4.59
Dec 29
9.60
9.22
9.87
7.14
Dec 30
10.01
9.82
10.11
3.01
Dec 31
10.09
9.92
10.23
3.21
Jan 01
10.25
9.94
10.49
5.57
Jan 02
10.03
9.86
10.16
3.05
Jan 03
9.67
9.55
9.77
2.38
Vir Biotechnology Daily Price Targets
Vir Biotechnology Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $10.17. Positive dynamics for Vir Biotechnology shares will prevail with possible volatility of 3.715%. Pessimistic target level: 10.01 Optimistic target level: 10.40
Vir Biotechnology Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $10.36. Positive dynamics for Vir Biotechnology shares will prevail with possible volatility of 4.570%. Pessimistic target level: 10.06 Optimistic target level: 10.54
Vir Biotechnology Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $9.99. Negative dynamics for Vir Biotechnology shares will prevail with possible volatility of 5.762%. Pessimistic target level: 9.64 Optimistic target level: 10.23
Vir Biotechnology Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $9.73. Negative dynamics for Vir Biotechnology shares will prevail with possible volatility of 5.869%. Pessimistic target level: 9.52 Optimistic target level: 10.12
Vir Biotechnology Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $9.54. Negative dynamics for Vir Biotechnology shares will prevail with possible volatility of 7.325%. Pessimistic target level: 9.18 Optimistic target level: 9.90
Vir Biotechnology Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $9.58. Positive dynamics for Vir Biotechnology shares will prevail with possible volatility of 4.122%. Pessimistic target level: 9.47 Optimistic target level: 9.87
499 ILLINOIS STREET, SUITE 500, SAN FRANCISCO, CA, US
Market Capitalization:
1 269 878 000 $
Market capitalization of the Vir Biotechnology, Inc. is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of VIR shares in the company outstanding by the market price of one share.
EBITDA:
-634 766 976 $
EBITDA of Vir Biotechnology is earnings before interest, income tax and depreciation of assets.
PE Ratio:
None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
None
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
-4.5
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
0.585
Quarterly Revenue Growth YOY:
-0.993
Trailing PE:
-
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
4.361
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
0.52
Enterprise Value (EV) /Revenue
EV To EBITDA:
0.789
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
134521000
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website